rs199474830
Variant summary
Our verdict is Likely pathogenic. The variant received 8 ACMG points: 8P and 0B. PM1PM2PP2PP3_ModeratePP5
The NM_001360016.2(G6PD):c.193A>G(p.Thr65Ala) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. T65N) has been classified as Uncertain significance.
Frequency
Consequence
NM_001360016.2 missense
Scores
Clinical Significance
Conservation
Publications
- anemia, nonspherocytic hemolytic, due to G6PD deficiencyInheritance: XL Classification: DEFINITIVE, STRONG Submitted by: ClinGen, Ambry Genetics, Labcorp Genetics (formerly Invitae)
- G6PD deficiencyInheritance: XL Classification: DEFINITIVE Submitted by: ClinGen
- class I glucose-6-phosphate dehydrogenase deficiencyInheritance: XL Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Likely_pathogenic. The variant received 8 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_001360016.2. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| G6PD | NM_001360016.2 | MANE Select | c.193A>G | p.Thr65Ala | missense | Exon 4 of 13 | NP_001346945.1 | ||
| G6PD | NM_000402.4 | c.283A>G | p.Thr95Ala | missense | Exon 4 of 13 | NP_000393.4 | |||
| G6PD | NM_001042351.3 | c.193A>G | p.Thr65Ala | missense | Exon 4 of 13 | NP_001035810.1 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| G6PD | ENST00000393562.10 | TSL:1 MANE Select | c.193A>G | p.Thr65Ala | missense | Exon 4 of 13 | ENSP00000377192.3 | ||
| G6PD | ENST00000696421.1 | c.193A>G | p.Thr65Ala | missense | Exon 4 of 13 | ENSP00000512616.1 | |||
| G6PD | ENST00000369620.6 | TSL:5 | c.193A>G | p.Thr65Ala | missense | Exon 4 of 13 | ENSP00000358633.2 |
Frequencies
GnomAD3 genomes Cov.: 24
GnomAD4 exome Cov.: 31
GnomAD4 genome Cov.: 24
ClinVar
Submissions by phenotype
Anemia, nonspherocytic hemolytic, due to G6PD deficiency Pathogenic:1Uncertain:1
Variant found in hemizygote with G6PD deficiency (PP4). Decreased activity in red blood cells of hemizygote and when expressed in E. coli (PS3). Not observed in gnomAD (PM2). Polyphen predicts as probably damaging, and further structural investigation indicates disruption of beta-alpha-beta motif and NADP binding site (PP3). Post_P 0.975 (odds of pathogenicity 350.3, Prior_P 0.1).
This variant is not present in population databases (ExAC no frequency). This sequence change replaces threonine with alanine at codon 65 of the G6PD protein (p.Thr65Ala). The threonine residue is highly conserved and there is a small physicochemical difference between threonine and alanine. This variant has been reported in an individual affected with G6PD deficiency (PMID: 25189226). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function do not agree on the potential impact of this missense change (SIFT: "Tolerated"; PolyPhen-2: "Possibly Damaging"; Align-GVGD: "Class C0").
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at